• American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis Arthritis Care & Research 2012; 64(6): 797– 808.

• Arrizabalaga P. El diafragma de filtración glomerular. Orientación diagnóstica y terapéutica en el síndrome nefrótico. NEFROLOGÍA 2005; 25(4):361-368.

• Carranza K, Dolores Veron, Alicia Cercado, Noemi Bautista, Pozo W, Tufro A, Veron D. Aspectos celulares y moleculares de la nefropatía diabética, rol del VEGF-A. Nefrologia 2015; 35(2):131-138

• Casanova González, Marta Patricia; Rodríguez Zamora, David; González Pérez, Aldo Luis. El riñón en las enfermedades sistémicas. MediSur 2007; 5(1):42-51

• Consenso ALAD. Prevención, diagnóstico y tratamiento temprano de la Nefropatía Diabética. Revista ALAD 2009; XVII(3):106-114

• Corapi et al. Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials. Arthritis Research & Therapy 2015; 17:110-121

• Davenport A and Giampaolo Merlini G. Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities. Nephrol Dial Transplant 2012; 27: 3713–3718

• David W Johnson. Global Proteinuria Guidelines: Are We Nearly There Yet? Clin Biochem Rev 2011 May; 32(2): 89–95

• Dember L. Amyloidosis-Associated Kidney Disease. J Am Soc Nephrol 2006; 17:3458–3471

• Denner S., Fernández V., Brissón C., Boncompagni L, Quiroga J. Control de calidad del examen del sedimento urinario: una experiencia piloto. FABICIB 2009; 13: 135-141

• Denton CP. Renal manifestations of systemic sclerosis—clinical features and outcome assessment. Rheumatology 2008;47:54–56

• Detlef O. Schlondorff. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney International (2008) 74:860–866

• Dimopoulos MA et al. Renal failure in mieloma. Leukemia 2008; 22: 1485–1493

• Eliot C. Heher, Helmut G. Rennke, Jacob P. Laubach, and Paul G. Richardson. Kidney Disease and Multiple MyelomaClin J Am Soc Nephrol 2013; 8: 2007–2017

• Eliot C. Heher, Nelson B. Goes, Thomas R. Spitzer, Noopur S. Raje, Benjamin D. Humphreys, Kenneth C. Anderson,4 and Paul G. Richardson. Kidney disease associated with plasma cell discrasias. BLOOD 2010; 116: 1397-1404

• Farreras-Rozman: “Medicina Interna”. Mosby/Doyma Libros. 16th ed. 2008

• Fernández D., Di Chiazza S., Veyretou F., González L, Romero M. Análisis de orina: estandarización y control de calidad. Acta Bioquím Clín Latinoam 2014; 48 (2): 213-21

• Fierro J. Nefropatía diabética: Fisiopatología, diagnóstico, evolución clínica y epidemiología. Rev. Med. Clin. Condes 2009; 20(5):639–650

• Fraga A (SAN), Inserra F (SAN), Alles A (SAN), Gómez A (ABA), Mazziotta D (FBA). Documento multidisciplinario para la detección precoz de Enfermedad Renal Crónica. Fundación Bioquímica Argentina-Sociedad Argentina de Nefrología-Asociación Bioquímica Argentina, Acta Bioquím Clín Latinoam 2010; 44(3): 377-84

• García Ramírez M, García Martínez E. Afectación renal en las enfermedades sistémicas. Protoc diagn ter pediatr 2014;1:333-53

• González Álvarez MT. Nefrología. Conceptos básicos en atención primaria. Marge Medica Books. 2009

• González de Buitrago, J.M. Técnicas y métodos de laboratorio clínico. Masson. 2004 2 ª ed.

• González de Buitrago: “Patología Molecular”. Interamericana-McGraw-Hill. 2001

• Harrison: “Principios de Medicina Interna”. Interamericana.17th ed. 2008

• Henry: Laboratorio. Ed. Marbán. 2007

• Imai N. Standardizlng Assays of Total Protein in Urine. Clin Chem 1995; 32:1986.

• International Myeloma Working Group. Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the of the International Myeloma Working Group. JCO 2010. 28(33): 4976-4984

• Jah V et al. Chronic kidney disease: global dimension and perspectives. The Lancet 2013; 382:260-272

• Johnson D. Global Proteinuria Guidelines: Are We Nearly There Yet? Clin Biochem Rev 2011;32(2): 89–95

• Kallemuchikkal U, Gorevic K. Evaluation of Cryoglobulins. Arch Pathol Lab Med 1999; 123: 119-125

• KDIGO Clinical Practice Guideline for Acute Kidney Injury, Marzo 2012 disponible en http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO%20AKI%20Guideline.pdf

• Khalighi M, Wallace W and Palma-Diaz M. Amyloid nephropathy. Clin Kidney J (2014) 7: 97–106

• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter., Suppl. 2013; 3: 1–150

• Kronbichler A and Mayer G. Renal involvement in autoimmune connective tissue diseases. BMC Medicine 2013, 11:95-119

• Lambers Heerspink H. Alkalinization of urine samples preserves albumin concentrations during prolonged frozen storage in patients with diabetes mellitus. Diabetic Med 2009;26:556-9

• Levey, Stevens, Coresh. Conceptual Model for CKD (revised). Am J Kidney Dis 2009; 53 S3: S4-S16

• Marijn M. Speeckaert, Reinhart Speeckaert, Lien Van De Voorde, and Joris R. Delanghe. Immunochemically unreactive albumin in urine: fiction or reality? Critical Reviews in Clinical Laboratory Sciences 2011, 48(2): 87-96

• Matthew T James, Brenda R Hemmelgarn, Marcello Tonelli. Early recognition and prevention of chronic kidney disease. Lancet 2010; 375: 1296–309

• Merlini G. and Bellotti V. Molecular Mechanisms of Amyloidosis. N Engl J Med 2003; 349:583-96

• Miller et al. Current Issues in Measurement and Reporting of Urinary Albumin Excretion. Clinical Chemistry 2009. 55: 24-38

• Montañés Bermúdez R, Gràcia García S, Pérez Surribas D, Martínez Castelao A, Bover Sanjuán J. Documento de Consenso. Recomendaciones sobre la valoración de la proteinuria en el diagnóstico y seguimiento de la enfermedad renal crónica. Nefrologia 2011;31(3):331-45

• Olmos Pablo y col. Fisiopatología de la retinopatía y nefropatía diabéticas. Rev. méd. Chile 2009; 137( 10 ): 1375-1384

• Palumbo A and Anderson K. Multiple Myeloma. N Engl J Med 2011; 364:1046-60

• Rajashekar A1, Perazella MA, Crowley S. Systemic diseases with renal manifestations. Prim Care 2008;35(2):297-328

• Renal Pathology Society. Pathologic Classification of Diabetic Nephropathy on behalf of the Renal Pathology SocietyJ Am Soc Nephrol 2010; 21:556–563

• Schlondorff Detlef O. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney International 2008; 74:860–866

• Shihabi Z. Review: Cryoglobulins: An Important but Neglected Clinical Test. Annals of Clinical & Laboratory Science 2006;36(4):395-408

• Stompor T, Zabłocki M, Pankrac K. Renal involvement in multiple mieloma. Pol Arch Med Wewn 2012; 122 (9): 443-448